glp 1 lab monitoring test GLP-1 Metabolic Health Test Starting a GLP-1 medication? Knowing
Description
Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without Metformin
Many members don't know whether their employer opted in
doi: 10.1111/dom.13137 [DOI] [PubMed] [Google Scholar] 34
Opaka B, onierczuk M, Grabowska M
This approach contradicts the FDAs approval of the medication for people with BMIs of 30 or higher, or 27 or higher with a comorbidity
doi: 10.2337/diabetes.47.5.764
